SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009066
Filing Date
2024-06-12
Accepted
2024-06-12 09:15:20
Documents
13
Period of Report
2024-06-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K viri-20240611x8k.htm   iXBRL 8-K 42763
  Complete submission text file 0001558370-24-009066.txt   164154

Data Files

Seq Description Document Type Size
2 EX-101.SCH viri-20240611.xsd EX-101.SCH 3116
3 EX-101.LAB viri-20240611_lab.xml EX-101.LAB 15920
4 EX-101.PRE viri-20240611_pre.xml EX-101.PRE 10047
16 EXTRACTED XBRL INSTANCE DOCUMENT viri-20240611x8k_htm.xml XML 4851
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 241037611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)